Discover Italian opportunities in Biotech

Discover Italian opportunities in Biotech

Italy full Logo


When it comes to Life Sciences, Italy is recognized worldwide as one of the most competitive countries for industrial as well as research activities. Global leaders, such as Sanofi, Pfizer, Eli Lilly, Merck KGaA, GlaxoSmithKline and Takeda have chosen Italy as one of their primary locations. Over the last years, the Italian Life Sciences industry has achieved a considerable number of excellent results, making the country a top-tier environment for investments in pharma, medical devices and biotechnologies. 

In 2019, the pharma industry registered a production value of € 34 bln, sealing a leadership position along with Germany (Farmindustria, 2020). Between 2013 and 2019, pharma R&D investments have increased by 31%, reaching a value of € 1.6 bln, compared to the European average of 24%, (The European House Ambrosetti, 2020). The therapeutic pipeline counts 375 biotech projects, with a solid specialization in the fields of oncology, infectious diseases and neuroscience (Assobiotec, 2020). Thanks to the strong synergy with the Italian expertise in machinery and mechatronics, the country also maintains a leadership position in the medical devices sector, with over 4,000 companies and 1.5 mln medical devices produced every year (Confindustria Dispositivi Medici, 2020). Moreover, 22% of the total number of clinical trials in Europe have been conducted in Italy in 2019 (AIFA, 2020). Since 1996, Italy has maintained a worldwide leadership position in terms of scientific citations in different Life Sciences-related fields, such as biochemistry, endocrinology, hepatology, internal medicine, reproductive medicine and so on (Scimago, 2020).

In addition to an extremely vibrant Life Sciences ecosystem, Italy also offers a wide range of financial aids and incentive schemes that respond to different investment projects. The team of Invest in Italy is available to support you in exploring the business opportunities of Italian Life Sciences, illustrate the different funding solutions and provide a broad array of free-of-charge services tailored according to your needs.